0001179110-18-012095.txt : 20181009
0001179110-18-012095.hdr.sgml : 20181009
20181009161254
ACCESSION NUMBER: 0001179110-18-012095
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181008
FILED AS OF DATE: 20181009
DATE AS OF CHANGE: 20181009
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vandervoort Adam C
CENTRAL INDEX KEY: 0001375088
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37477
FILM NUMBER: 181113792
MAIL ADDRESS:
STREET 1: 485 MADISON AVENUE
CITY: NEW YORK
STATE: NY
ZIP: 10022
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Teladoc Health, Inc.
CENTRAL INDEX KEY: 0001477449
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-OFFICES & CLINICS OF DOCTORS OF MEDICINE [8011]
IRS NUMBER: 043705970
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
BUSINESS PHONE: 2036352002
MAIL ADDRESS:
STREET 1: 2 MANHATTANVILLE ROAD
STREET 2: SUITE 203
CITY: PURCHASE
STATE: NY
ZIP: 10577
FORMER COMPANY:
FORMER CONFORMED NAME: Teladoc, Inc.
DATE OF NAME CHANGE: 20091123
4
1
edgar.xml
FORM 4 -
X0306
4
2018-10-08
0
0001477449
Teladoc Health, Inc.
TDOC
0001375088
Vandervoort Adam C
C/O TELADOC HEALTH, INC.,
2 MANHATTANVILLE ROAD, SUITE 203
PURCHASE
NY
10577
0
1
0
0
Chief Legal Officer, Secretary
Common Stock
2018-10-08
4
M
0
2734
8.71
A
2934
D
Common Stock
2018-10-08
4
M
0
456
9.60
A
3390
D
Common Stock
2018-10-08
4
M
0
914
12.21
A
4304
D
Common Stock
2018-10-08
4
M
0
1447
22.30
A
5751
D
Common Stock
2018-10-08
4
S
0
5551
73.83
D
200
D
Employee Stock Option (right to buy)
8.71
2018-10-08
4
M
0
2734
0.00
D
2025-02-25
Common Stock
2734
13670
D
Employee Stock Option (right to buy)
9.60
2018-10-08
4
M
0
456
0.00
D
2025-05-29
Common Stock
456
3645
D
Employee Stock Option (right to buy)
12.21
2018-10-08
4
M
0
914
0.00
D
2026-03-07
Common Stock
914
15530
D
Employee Stock Option (right to buy)
22.30
2018-10-08
4
M
0
1447
0.00
D
2027-03-03
Common Stock
1447
41955
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on June 5, 2018.
Represents the weighted average price of transactions ranging from $73.30 to $74.62. The reporting person undertakes to provide, upon request by the SEC staff, the issuer or any security holder of the issuer, full information regarding the number of shares sold at each separate price.
The option vests as to 25% of the shares on February 25, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on May 29, 2016. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 7, 2017. The remainder of the shares vest in 36 equal monthly installments thereafter.
The option vests as to 25% of the shares on March 3, 2018. The remainder of the shares vest in 36 equal monthly installments thereafter.
/s/ Adam C. Vandervoort
2018-10-09